Board Meeting Scheduled for October 7, 2026

Indrayani Biotech's Board will meet on October 7, 2026 to review and approve the unaudited financial results for the quarter ended June 30, 2026, and discuss the reconstitution of Board committees.

Wed 30 Sep 2026

Meeting Date

October 7, 2026

Financial Period

Quarter ended June 30, 2026

Agenda Item 1

Review and approve unaudited financial results (standalone and consolidated)

Agenda Item 2

Reconstitution of Board committees

About the meeting

Indrayani Biotech has called a Board meeting for October 7, 2026, under SEBI's Listing Obligations and Disclosure Requirements Regulations.

What will be discussed

• Unaudited Financial Results for the quarter ended June 30, 2026 (both standalone and consolidated), along with the Limited Review Report from the company's statutory auditors.
• Reconstitution of Board committees: The Board will consider proposals to reconstitute various Board committees.
• Any other business that the chair permits.

What this means

This is a scheduled governance meeting. Once the Board approves the quarterly results, they will be made public. Retail investors will then be able to see how the company performed in Q1 FY2027. The Limited Review Report indicates the auditors have reviewed (but not fully audited) these unaudited results. Committee reconstitution is routine housekeeping—it may reflect changes in Board composition or role assignments.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.